Anu's Laboratories to raise Rs 250 crore

The company is in manufacturing of bulk drug intermediates for the last 13 years and having leadership in most of its products being manufactured namely i.e 2,4-Dichloro-5 Fluoro Acetophenone and other high quality intermediates such as Chlorohexanone, 1,3-Dibromo Propane, Methyl-4 (4-Chloro 1 oxo butyl), Di-Methyl Acetate etc.,

Company has been working on various new processes taking advantage of its edge on process development, exploring the new export markets including regulatory markets with the coming up of new FDA plant at Vizag with outlay of Rs.63.00 crores and expanding the capacities in existing units and at other places including other states.

The board of directors has recommended the bonus shares in the ratio of 1: 1 i.e one bonus share for every one share held by the share holders.

Further, the Board of Directors have decided to take the approval from share holders for fund raising to the tune of Rs. 250 crores for further expansion, acquisition of facilities and enhancement of business horizon keeping in view of the arising opportunities in Bulk drug intermediates and APIs and exploring the opportunities in organic and inorganic growth.

Source : Equity Bulls

Keywords